Pioneering Medical Company Completes Trial For Pruritus Treatment

Tharimmune Inc. Completes Phase 1 Clinical Trial for TH104, Moves to Phase 2 for Chronic Pruritus Treatment.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

Tharimmune Inc., a pioneering biopharmaceutical company, has made a significant stride in the field of drug delivery and chronic pruritus treatment. The company recently announced the completion of its Phase 1…